VitaNova Life Sciences (VNOV) Assets Average (2018 - 2026)

VitaNova Life Sciences has disclosed Assets Average across 7 years of filings, most recently posting $2.3 million for Q3 2026.

• Assets Average for Q3 2026 came in at $2.3 million, up 4.16% year-over-year; the trailing twelve-month figure through Jul 2026 was $2.3 million (up 4.16% YoY), and the FY2026 annual result was $2.4 million, up 36.35% from the prior year.
• Assets Average for Q3 2026 stood at $2.3 million, down from $2.4 million in the prior quarter.
• Across five years, Assets Average topped out at $2.4 million in Q2 2026 and bottomed at $9870.5 in Q2 2023.
• Average Assets Average over 5 years is $1.1 million, with a median of $1.2 million recorded in 2024.
• The widest annual swing landed in 2023, when Assets Average tumbled 69.82%; it then soared 10827.58% in 2024.
• Year by year, Assets Average stood at $32537.0 in 2022, then tumbled by 69.66% to $9870.5 in 2023, then jumped by 12359.67% to $1.2 million in 2024, then soared by 86.15% to $2.3 million in 2025, then grew by 2.34% to $2.3 million in 2026.
• The last three Assets Average figures came in at $2.3 million (Q3 2026), $2.4 million (Q2 2026), and $2.3 million (Q1 2026), per Business Quant data.